SEARCH

Current Edition

GDPR and the implications on real world research 2
Volume 1 Issue 2

GDPR and the Implications on Real World Research

As of 25th May 2018, the European General Data Protection Regulation (GDPR) became applicable in all member states. There has been a lot of hype, …

Continue Reading →
Treating cancer by taking the brakes off 1
Volume 1 Issue 2

Treating Cancer by Taking the Brakes Off the Immune System: Modelling Immune-oncology Drugs in preclinical Development

A wide range of targets are currently under investigation for the treatment of cancer. One of the most exciting developments is the utilisation of the …

Continue Reading →
Situation critical_antimicrobial resistance 1
Volume 1 Issue 2

Situation Critical: Antimicrobial Resistance

The global crisis of antimicrobial resistance (AMR) and the ever-decreasing supply of effective antibiotics are reaching a critical point. Two years on from Lord O’Neil’s …

Continue Reading →
How to stem the tide of data deluge 1
Volume 1 Issue 2

How to Stem the Tide of Data Deluge to Produce Better Science in Biopharma R&D

Today, being a scientist is tough, especially if we consider biopharma R&D through the lens of generating new insight and knowledge. As a community, we …

Continue Reading →
Applications of functional protein 1
Volume 1 Issue 2

Applications of Functional Protein Arrays for Detection and Development of Autoantibody-based Diagnostic and Therapeutic

The human immune system is a key line of defence against foreign pathogens. AAb production is an important indicator of  autoimmune diseases but is not …

Continue Reading →
The sweet threat 1
Volume 1 Issue 2

The Sweet Threat

DNA, RNA and proteins are not the only ways for living organisms to encode information and to communicate. Glycoconjugates and their cognate receptors, the C-type …

Continue Reading →
Chemstress biomanufacturing process control
Volume 1 Issue 2

Biomanufacturing Process Control

Chinese hamster ovary (CHO) cells, the powerhouse of the biopharmaceutical industry, are inherently variable. This functional heterogeneity is what makes them such a valuable tool …

Continue Reading →
Biological sample catalogues_enabling 1
Volume 1 Issue 2

Biological Sample Catalogues – Enabling Biorepository Collaboration to Foster Effective Research

To identify effective new drugs, life sciences researchers need to access specific biological sample sets to identify biomarkers which can be used to accurately diagnose …

Continue Reading →
Regulatory convergence in European 1
Volume 1 Issue 2

Regulatory Convergence in European Life Sciences

The regulatory environment for the life sciences industry is undergoing fundamental changes in Europe. These changes are far-reaching and will have significant impacts which will …

Continue Reading →
Role and significance of notified bodies 1
Volume 1 Issue 2

Role and Significance of Notified Bodies under the New Medical Devices Regulation and the In Vitro Diagnostics Regulation

On 25 May 2017, the new Medical Devices Regulation and the In Vitro Diagnostics Regulation (IVDR) entered into force. The MDR and the IVDR both …

Continue Reading →
A look to lessons past_why biopharma 1
Volume 1 Issue 2

A Look to Lessons Past: Why Biopharma Should Make Use of Small Molecule Expertise

The past decade has seen unprecedented growth in the biopharmaceutical industry, with the global compound annual growth rate (CAGR) estimated to reach 8.5% between 2017 …

Continue Reading →
Regulatory compliance_how LIMS can support 1
Volume 1 Issue 2

Regulatory Compliance – How LIMS Can Support the 10 Principles of GMP

Laboratory information management systems (LIMS) are used extensively in pharmaceutical laboratories to manage, track and report on samples, tests, test results and more. Laboratory testing …

Continue Reading →
How to ensure the safety of temperature 2
Volume 1 Issue 2

How to Ensure the Safety of Temperature-sensitive Clinical Trial Medication

Patient safety is the top priority of every clinical trial. Therefore, it is vital the investigational medicinal product (IMP) dispensed to the patient is both …

Continue Reading →
Using blockchain to address interoperability 1
Volume 1 Issue 2

Using Blockchain to Address Interoperability Concerns in Healthcare

Government and public health authorities are undertaking several initiatives to boost the health IT system, which in turn is expected to enable high-quality and personalised …

Continue Reading →